2010
Siglec-G Regulates B1 Cell Survival and Selection.
Jellusova J,
Duber S,
Guckel E,
Binder CJ,
Weiss S,
Voll R,
Nitschke L.
J Immunol. 2010 Sep 15;185(6):3277-84. Epub 2010 Aug 20.
2010
Molecular pathogenesis of Philadelphia chromosome-negative chronic myeloproliferative neoplasms.
Jager R,
Kralovics R.
Curr Cancer Drug Targets. 2010 Nov 10.
2010
Molecular basis and clonal evolution of myeloproliferative neoplasms.
Jager R,
Kralovics R.
Haematologica. 2010 Apr;95(4):526-9.
2010
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.
Jager R,
Gisslinger H,
Passamonti F,
Rumi E,
Berg T,
Gisslinger B,
Pietra D,
Harutyunyan A,
Klampfl T,
Olcaydu D,
Cazzola M,
Kralovics R.
Leukemia. 2010 Jul;24(7):1290-8. Epub 2010 May 27.
2010
Genomic Imprinting Mechanisms In Embryonic And Extra-Embryonic Mouse Tissues.
Hudson QJ,
Kulinski TM,
Huetter SP,
Barlow DP.
Heredity. 2010 Jul;105(1):45-56. Epub 2010 Mar 17.
2010
Anti-inflammatory properties of the phosphoinositide- 3 kinase (PI3K) pathway are mediated by IL- 10/DUSP regulation.
Guenzl P,
Hainzl E,
Matt U,
Dillinger B,
Mahr B,
Knapp S,
Binder BR,
Schabbauer G.
J Leukoc Biol. J Leukoc Biol. 2010 Dec;88(6):1259-69. Epub 2010 Sep 30.
2010
Peroxisomes are signaling platforms for antiviral innate immunity.
Dixit E,
Boulant S,
Zhang Y,
Lee AS,
Odendall C,
Shum B,
Hacohen N,
Chen ZJ,
Whelan SP,
Fransen M,
Nibert ML,
Superti-Furga G,
Kagan JC.
Cell. 2010 May 14;141(4): 668-81. Epub 2010 May 6.
2010
When monocytes come (too) close to our hearts.
Cardilo-Reis L,
Witztum JL,
Binder CJ.
J Am Coll Cardiol. 2010 Apr 13;55(15):1639-41.
2010
A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib.
Burkard TR,
Rix U,
Breitwieser FP,
Superti-Furga G,
Colinge J.
PLoS Comput Biol. 2010 Nov 18;6(11):e1001001.
